356 related articles for article (PubMed ID: 35142987)
1. Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.
Cheng YY; Chen BY; Bian GL; Ding YX; Chen LW
Mol Neurobiol; 2022 Apr; 59(4):2642-2655. PubMed ID: 35142987
[TBL] [Abstract][Full Text] [Related]
2. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
3. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice.
Selvakumar GP; Ahmed ME; Thangavel R; Kempuraj D; Dubova I; Raikwar SP; Zaheer S; Iyer SS; Zaheer A
Brain Behav Immun; 2020 Jul; 87():429-443. PubMed ID: 31982500
[TBL] [Abstract][Full Text] [Related]
4. Imperatorin inhibits oxidative stress injury and neuroinflammation via the PI3K/AKT signaling pathway in the MPTP-induced Parkinson's disease mouse.
Liu L; Jiang L; Zhang J; Ma Y; Wan M; Hu X; Yang L
Neuroreport; 2024 Feb; 35(3):175-184. PubMed ID: 38305108
[TBL] [Abstract][Full Text] [Related]
5. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
Zhang J; Wang M; Zhao Y; Zhang Y; Gao Y; Zhang X; Yang G
Neurosci Lett; 2022 Jun; 781():136669. PubMed ID: 35490905
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
7. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
[TBL] [Abstract][Full Text] [Related]
8. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
[TBL] [Abstract][Full Text] [Related]
9. Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson's disease.
Leem YH; Kim DY; Park JE; Kim HS
Sci Rep; 2023 May; 13(1):8783. PubMed ID: 37258791
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of
Bai X; Zhang X; Fang R; Wang J; Ma Y; Liu Z; Dong H; Li Q; Ge J; Yu M; Fei J; Sun R; Huang F
Aging (Albany NY); 2021 Sep; 13(18):22390-22411. PubMed ID: 34543233
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
[TBL] [Abstract][Full Text] [Related]
13. Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease.
Ma C; Liu Y; Li S; Ma C; Huang J; Wen S; Yang S; Wang B
CNS Neurosci Ther; 2023 Jul; 29(7):2018-2035. PubMed ID: 36914567
[TBL] [Abstract][Full Text] [Related]
14. The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.
Rabaneda-Lombarte N; Serratosa J; Bové J; Vila M; Saura J; Solà C
J Neuroinflammation; 2021 Apr; 18(1):88. PubMed ID: 33823877
[TBL] [Abstract][Full Text] [Related]
15. Depression Induced by Chronic Unpredictable Mild Stress Increases Susceptibility to Parkinson's Disease in Mice via Neuroinflammation Mediated by P2X7 Receptor.
Ren C; Li LX; Dong AQ; Zhang YT; Hu H; Mao CJ; Wang F; Liu CF
ACS Chem Neurosci; 2021 Apr; 12(7):1262-1272. PubMed ID: 33734697
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
Zhang J; Sun B; Yang J; Chen Z; Li Z; Zhang N; Li H; Shen L
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039876
[TBL] [Abstract][Full Text] [Related]
17. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
[TBL] [Abstract][Full Text] [Related]
18. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
Guo L; Li Y; Li W; Qiu J; Du J; Wang L; Zhang T
Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1221-1231. PubMed ID: 36054693
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.
Hwang CJ; Choi DY; Jung YY; Lee YJ; Yun JS; Oh KW; Han SB; Oh S; Park MH; Hong JT
Horm Behav; 2016 Apr; 80():19-29. PubMed ID: 26836768
[TBL] [Abstract][Full Text] [Related]
20. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
